A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy.

Por Shibamoto, Y., Ohshio, G., Hosotani, R., Nishimura, Y., Manabe, T., Imamura, M., Abe, M.
Publicado em 1997

Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction.

Por Inoue, K, Tobe, T, Suzuki, T, Hosotani, R, Kogire, M, Fuchigami, A, Miyashita, T, Tsuda, K, Seino, Y
Publicado em 1987

Release of cholecystokinin and gallbladder contraction before and after gastrectomy.

Por Inoue, K, Fuchigami, A, Hosotani, R, Kogire, M, Huang, Y S, Miyashita, T, Suzuki, T, Tsuda, K, Seino, Y, Rayford, P L
Publicado em 1987

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer

Por Ohkawa, S, Okusaka, T, Isayama, H, Fukutomi, A, Yamaguchi, K, Ikeda, M, Funakoshi, A, Nagase, M, Hamamoto, Y, Nakamori, S, Tsuchiya, Y, Baba, H, Ishii, H, Omuro, Y, Sho, M, Matsumoto, S, Yamada, N, Yanagimoto, H, Unno, M, Ichikawa, Y, Takahashi, S, Watanabe, G, Wakabayashi, G, Egawa, N, Tsuda, M, Hosotani, R, Hamada, C, Hyodo, I
Publicado no Br J Cancer (2015)